Diagnosis

  • AI to co-read 250,000 breast scans yearly in Stockholm

    Stockholm Region is rolling out AI as an independent second reader across its breast screening programme, covering up to 250,000 mammograms a year.

  • Trust to decide how far back to review unnecessary breast cancer surgeries

    A health trust will decide how far back to review breast cancer cases after more than 30 women were found to have undergone unnecessary surgery. It has already been established that hundreds of patients came to harm during treatment at the breast unit at County Durham and Darlington Foundation Trust (CDDFT). The trust has apologised [...]

  • Breast cancer patients face ‘postcode lottery’ for new drug

    Breast cancer patients in Scotland face a postcode lottery that could limit access to two newly approved NHS treatments. The Scottish Medicines Consortium has approved Elacestrant and Capivasertib, which could be life-extending for some people with metastatic breast cancer. Eligibility depends on genetic testing to confirm gene mutations before treatment can be prescribed, but the [...]

  • New test could cut need for invasive womb cancer checks

    A urine and vaginal fluid test could help rule out womb cancer in women with postmenopausal bleeding, potentially reducing invasive checks. In a study of 1,864 women with postmenopausal bleeding, the test identified 80 of 99 womb cancers and correctly gave a negative result for 93 per cent of women without the disease. Researchers said [...]

  • Targeted nanotherapy shows endometriosis promise

    A targeted nanotherapy reduced endometriosis lesions and pain sensitivity after a single dose in mice, early research has found. The experimental treatment uses a nanoparticle to deliver an existing drug to immune cells associated with endometriosis. Researchers hope the approach could eventually lead to a treatment for people with the chronic condition, but it has [...]

  • Charity launches Women’s Health Plan to tackle inequalities in long-term conditions

     Chest Heart & Stroke Scotland has launched a three-year Women’s Health Plan setting out actions to improve prevention, diagnosis, treatment and support for women in Scotland. The 2026 to 2029 plan includes commitments on health information, prevention and early detection, professional training, peer support, post-diagnosis care, policy and research. It comes amid disparities affecting women [...]

  • Gender gap in treatment persists even when men and women have same condition

    Women with the same medical conditions as men were less likely to receive the same treatment across several specialties, a global research review found. The review found differences in care for conditions including cardiovascular disease, kidney disease and Parkinson’s, with women less likely to receive some active treatments. Of 38 studies analysed, 33 found women [...]

  • Menopause frequently missing from electronic health records – study

    Menopause is often absent from women's electronic health records, a study of nearly 396,000 women has found. Researchers found menopause appeared almost seven times more often in participant surveys than in electronic health records (EHRs). The findings suggest important reproductive health information, including age at menopause, may often be missing from health records used for [...]

  • FDA approves AstraZeneca breast cancer drug

    The FDA has granted accelerated approval to AstraZeneca drug Etcamah for certain adults with advanced breast cancer carrying an ESR1 mutation. Etcamah, also known as camizestrant, was approved in combination with a CDK4/6 inhibitor, either abemaciclib, palbociclib or ribociclib. The treatment is for adults with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer when [...]

  • New universal heart attack definition could transform care for women

    Four leading cardiovascular health groups have agreed new guidance for healthcare professionals assessing patients with suspected heart attacks. Historically, some less common forms of heart attack, which evidence shows affect women far more than men, have been classified as less important, with treatment and care often worse as a result. Experts said women [...]